DEXCOM, INC. (DXCM) Share buybacks
- Total buybacks · last 12 months (USD): Value $1.10B; Formula and calculation Trailing-year cash paid for share repurchases. Period ending 2026-06-30..
- Buyback yield · 12 months: Value (m); Formula and calculation Cash paid for share repurchases / current market cap. Period ending 2026-06-30..
Share buybacks
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total buybacks · last 12 months (USD) | $1.10B | Trailing-year cash paid for share repurchases. Period ending 2026-06-30. |
| Buyback yield · 12 months | (m) | Cash paid for share repurchases / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Buybacks · 12 months | 1.10B USD | Payments for Repurchase of Common Stock |
| Market cap | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total buybacks | Market cap (USD) | Buyback yield |
|---|---|---|---|
| 2026-06-30 | $1.10B | (m) | (m) |
| 2025-12-31 | $500.00M | (m) | (m) |
| 2025-09-30 | $187.20M | (m) | (m) |
| 2025-06-30 | $750.00M | (m) | (m) |
| 2024-12-31 | $750.00M | (m) | (m) |
| 2024-09-30 | $1.25B | (m) | (m) |
| 2024-06-30 | $500.00M | (m) | (m) |
| 2023-12-31 | $688.70M | (m) | (m) |
| 2023-09-30 | $188.70M | (m) | (m) |
| 2023-06-30 | $746.40M | (m) | (m) |
| 2023-05-31 | (m) | (m) | (m) |
| 2022-12-31 | $557.70M | (m) | (m) |
| 2022-09-30 | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) |
| 2021-12-31 | $0.00 | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) |
| 2020-12-31 | $0.00 | (m) | (m) |
| 2019-12-31 | $0.00 | (m) | (m) |
| 2018-12-31 | $100.00M | (m) | (m) |
| 2017-12-31 | $0.00 | (m) | (m) |
| 2016-12-31 | $0.00 | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |